Melanie H. Jacobson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Melanie H. Jacobson has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
Leonardo Trasande
Division of Environmental Pediatrics, Department of Pediatrics, New York University Langone Medical Center, New York, New York
11 shared publicationsMengling Liu
Department of Population Health, New York University Langone Medical Center, New York, New York
6 shared publications- Akhgar Ghassabian
Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States; Departments of Pediatrics, New York University Grossman School of Medicine, New York, NY, United States
4 shared publications Kurunthachalam Kannan
Division of Environmental Pediatrics, Department of Pediatrics, New York University Langone Medical Center, New York, New York
4 shared publications- Leonardo Trasande
Department of Pediatrics, NYU Grossman School of Medicine, New York, USA
4 shared publications - Mengling Liu
Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA
4 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
Identification and dating of pregnancies in administrative healthcare claims databases: An updated, transparent, and transportable algorithm
Studies using routinely collected healthcare data are essential for understanding the benefit–risk profile of medications in pregnancy. However, reproducibility is limited by the lack of shared pregnancy identification algorithms, and generalizability is constrained by their development primarily in commercial insurance databases. A previously developed pregnancy identification algorithm was updated for ICD-10-CM and translated into a standardized format to support transport across diverse databases. Algorithm implementation characteristics were evaluated in three US health insurance claims databases (2000-2025), including commercially and publicly insured populations. Overall, 5.8 million and 3.0 million pregnancies were identified in two commercial databases (Merative™ and Optum) and 2.3 million pregnancies in Merative™ MarketScan® Multi-State Medicaid Database (MDCD). Across databases, live birth prevalence ranged from 76–83%, miscarriage/abortion 15–23%, ectopic pregnancy 1%, and stillbirth ≤0.5%, with a higher proportion of live births in MDCD. Pregnancy dating methods varied substantially across coding eras: use of gestational age records increased from 4-9% in the ICD-9-CM era to 87–92% during the ICD-10-CM era, with greater use in MDCD. Using a standardized algorithm, this study demonstrates how database characteristics and coding transitions influence pregnancy identification and dating in healthcare data, highlighting methodological considerations for reproducible pregnancy research across data sources.
- 5 November 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
Open AccessIdentification and dating of pregnancies in administrative healthcare claims databases: An updated, transparent, and transportable algorithm
Studies using routinely collected healthcare data are essential for understanding the benefit–risk profile of medications in pregnancy. However, reproducibility is limited by the lack of shared pregnancy identification algorithms, and generalizability is constrained by their development primarily in commercial insurance databases. A previously developed pregnancy identification algorithm was updated for ICD-10-CM and translated into a standardized format to support transport across diverse databases. Algorithm implementation characteristics were evaluated in three US health insurance claims databases (2000-2025), including commercially and publicly insured populations. Overall, 5.8 million and 3.0 million pregnancies were identified in two commercial databases (Merative™ and Optum) and 2.3 million pregnancies in Merative™ MarketScan® Multi-State Medicaid Database (MDCD). Across databases, live birth prevalence ranged from 76–83%, miscarriage/abortion 15–23%, ectopic pregnancy 1%, and stillbirth ≤0.5%, with a higher proportion of live births in MDCD. Pregnancy dating methods varied substantially across coding eras: use of gestational age records increased from 4-9% in the ICD-9-CM era to 87–92% during the ICD-10-CM era, with greater use in MDCD. Using a standardized algorithm, this study demonstrates how database characteristics and coding transitions influence pregnancy identification and dating in healthcare data, highlighting methodological considerations for reproducible pregnancy research across data sources.
- Open Access
- 18 September 2025
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 34 (9) , e70196
A Systematic Review of Algorithms for Identifying Pediatric Neurodevelopmental Outcomes
Purpose: Investigating pediatric neurodevelopmental outcomes (NDO) in studies using secondary data is often challenging due to heterogeneous clinical definitions and medical coding systems. This study aims to identify the algorithms used to define NDO in studies using electronic healthcare data through a systematic literature review. Methods: A search strategy was developed to identify studies on NDO that describe phenotype algorithms from January 1, 2010, to March 10, 2025. The search strategy included terms to identify studies containing algorithms for NDO as an outcome, routinely collected healthcare data, epidemiologic designs likely to incorporate algorithms, and pregnant individuals and/or infants/children. Two independent reviewers assessed eligibility criteria and performed data extraction, with inconsistencies reviewed by a third reviewer. Descriptive statistics were used to summarize categorical and continuous variables appropriately. Results: The review included 156 publications that implemented algorithms for NDO, with 18 of these studies validating the outcomes. Most publications studied autism spectrum disorder (ASD) ( n = 103, 65.6%) and attention deficit hyperactivity disorder (ADHD) ( n = 72, 45.9%) either as a single outcome or as a composite. Conclusions: Instead of presenting NDO as a composite outcome, it is recommended to present multiple single outcomes. Validated outcomes in data from Nordic countries demonstrate a high positive predictive value when using one code for diagnoses, while more complex algorithms are required for US data. Clearly detailing and establishing the time of assessment for each NDO is critical to inform valid epidemiological estimates.
- 18 September 2025
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 34 (9) , e70196
Open AccessA Systematic Review of Algorithms for Identifying Pediatric Neurodevelopmental Outcomes
Purpose: Investigating pediatric neurodevelopmental outcomes (NDO) in studies using secondary data is often challenging due to heterogeneous clinical definitions and medical coding systems. This study aims to identify the algorithms used to define NDO in studies using electronic healthcare data through a systematic literature review. Methods: A search strategy was developed to identify studies on NDO that describe phenotype algorithms from January 1, 2010, to March 10, 2025. The search strategy included terms to identify studies containing algorithms for NDO as an outcome, routinely collected healthcare data, epidemiologic designs likely to incorporate algorithms, and pregnant individuals and/or infants/children. Two independent reviewers assessed eligibility criteria and performed data extraction, with inconsistencies reviewed by a third reviewer. Descriptive statistics were used to summarize categorical and continuous variables appropriately. Results: The review included 156 publications that implemented algorithms for NDO, with 18 of these studies validating the outcomes. Most publications studied autism spectrum disorder (ASD) ( n = 103, 65.6%) and attention deficit hyperactivity disorder (ADHD) ( n = 72, 45.9%) either as a single outcome or as a composite. Conclusions: Instead of presenting NDO as a composite outcome, it is recommended to present multiple single outcomes. Validated outcomes in data from Nordic countries demonstrate a high positive predictive value when using one code for diagnoses, while more complex algorithms are required for US data. Clearly detailing and establishing the time of assessment for each NDO is critical to inform valid epidemiological estimates.
- Open Access
- 13 September 2025
- Published by Springer Nature in Drug Safety
- Vol. 49 (3) , 273-289
Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review
Major congenital malformations (MCMs) are a primary outcome of interest in pregnancy safety studies. This study aimed to identify and summarize algorithms used to identify MCMs in routinely collected healthcare data sources in the USA, Canada, and Europe by conducting a systematic literature review. We developed a search strategy to identify studies containing algorithms for MCMs from January 1, 2010, to April 11, 2025. Search terms included those related to MCMs as an outcome, routinely collected healthcare data, epidemiologic designs likely to incorporate algorithms, and pregnant individuals and/or infants. Study review and data extraction was conducted in duplicate using a standardized data collection form. Among the initially identified 2242 studies, 974 were selected for full-text review. Of these, 70.3% were excluded, leaving 289 studies. Over half (58.1%) of the included studies were from Europe, predominantly from Nordic countries using national register data (N = 135; 80.4%). Studies using claims (18.0%) or hospital discharge data (16.3%) were also common. Although there was heterogeneity in the timing of MCM assessment, 55.7% of studies collected MCMs through the infant's first year of life. Overall, algorithms varied across data source type and geography in the codes specified, rules, utilization of maternal versus infant records, and coding system. There were 27 (9.3%) validation studies, 70.4% of which were based on claims and/or electronic health record data only. Most had positive predictive values >70%, though this varied according to MCM type or anatomical site. We provide the first comprehensive systematic literature review of algorithms used to identify MCMs in routinely collected healthcare data, aiding researchers in their ability to generate reliable evidence in pregnancy safety pharmacoepidemiology.
- 13 September 2025
- Published by Springer Nature in Drug Safety
- Vol. 49 (3) , 273-289
Open AccessAlgorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review
Major congenital malformations (MCMs) are a primary outcome of interest in pregnancy safety studies. This study aimed to identify and summarize algorithms used to identify MCMs in routinely collected healthcare data sources in the USA, Canada, and Europe by conducting a systematic literature review. We developed a search strategy to identify studies containing algorithms for MCMs from January 1, 2010, to April 11, 2025. Search terms included those related to MCMs as an outcome, routinely collected healthcare data, epidemiologic designs likely to incorporate algorithms, and pregnant individuals and/or infants. Study review and data extraction was conducted in duplicate using a standardized data collection form. Among the initially identified 2242 studies, 974 were selected for full-text review. Of these, 70.3% were excluded, leaving 289 studies. Over half (58.1%) of the included studies were from Europe, predominantly from Nordic countries using national register data (N = 135; 80.4%). Studies using claims (18.0%) or hospital discharge data (16.3%) were also common. Although there was heterogeneity in the timing of MCM assessment, 55.7% of studies collected MCMs through the infant's first year of life. Overall, algorithms varied across data source type and geography in the codes specified, rules, utilization of maternal versus infant records, and coding system. There were 27 (9.3%) validation studies, 70.4% of which were based on claims and/or electronic health record data only. Most had positive predictive values >70%, though this varied according to MCM type or anatomical site. We provide the first comprehensive systematic literature review of algorithms used to identify MCMs in routinely collected healthcare data, aiding researchers in their ability to generate reliable evidence in pregnancy safety pharmacoepidemiology.
- 8 August 2025
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 34 (8) , e70189
Review of Mother–Infant Linkage Algorithms in Health Care Data Sources
Introduction: Studies that use health care data to assess infant outcomes following maternal medication use in pregnancy require linkage of maternal and infant records. While such linkage is increasing among established and emerging data sources, linkage methods are heterogeneous and have not been thoroughly reviewed or evaluated to inform fitness for use. The objective of this study was to describe methods used to link maternal and infant records in health care databases for pharmacoepidemiology research.Methods: Multiple Medline searches were conducted using structured terms and known mother–infant linked data sources. Reference sections of identified key papers were also reviewed. From each publication, we abstracted information on the type(s) of data sources, data fields used for the linkage, linkage methodology, and any results of record linkage evaluation.Results: We reviewed 114 publications describing mother–infant linkages published from 1990 to 2025 that used data from North and South America, Europe, Asia, and Oceania. Linkage methods using administrative claims data only primarily relied on family ID and estimated dates of maternal delivery and infant birth; proportions of mothers linked with infants were 56%–90%. Use of vital records, such as birth certificates, alongside claims data resulted in higher linkage proportions (> 86% of deliveries); examples were identified in Taiwan, Europe, and several US states. Utilization of birth records together with hospital discharge data resulted in linkages of over 90% of deliveries. Linkages involving additional data types, such as electronic health records, were identified in Europe and the US. Mother–infant linkages were straightforward in regions with national birth registers that include identifiers for mother and infant, such as the Nordic countries, and within integrated delivery networks in the US that provide both health insurance and care. Although most mother–infant linkages used deterministic methods, probabilistic methods typically achieved greater linkage proportions while requiring more data fields. Validations were uncommon; two studies demonstrated high positive predictive value (> 95%) but lower sensitivity (20%–88%).Discussion: Successful mother–infant data linkage occurs throughout the world and is enabled by aligned health care and technology infrastructure and policy. To increase trust in evidence generated from linked data, we encourage researchers and journals to include a description of linking methods, a quantification of linkage success, and, when possible, an assessment of linkage validity in peer‐reviewed publications.
- 8 August 2025
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 34 (8) , e70189
Review of Mother–Infant Linkage Algorithms in Health Care Data Sources
Introduction: Studies that use health care data to assess infant outcomes following maternal medication use in pregnancy require linkage of maternal and infant records. While such linkage is increasing among established and emerging data sources, linkage methods are heterogeneous and have not been thoroughly reviewed or evaluated to inform fitness for use. The objective of this study was to describe methods used to link maternal and infant records in health care databases for pharmacoepidemiology research.Methods: Multiple Medline searches were conducted using structured terms and known mother–infant linked data sources. Reference sections of identified key papers were also reviewed. From each publication, we abstracted information on the type(s) of data sources, data fields used for the linkage, linkage methodology, and any results of record linkage evaluation.Results: We reviewed 114 publications describing mother–infant linkages published from 1990 to 2025 that used data from North and South America, Europe, Asia, and Oceania. Linkage methods using administrative claims data only primarily relied on family ID and estimated dates of maternal delivery and infant birth; proportions of mothers linked with infants were 56%–90%. Use of vital records, such as birth certificates, alongside claims data resulted in higher linkage proportions (> 86% of deliveries); examples were identified in Taiwan, Europe, and several US states. Utilization of birth records together with hospital discharge data resulted in linkages of over 90% of deliveries. Linkages involving additional data types, such as electronic health records, were identified in Europe and the US. Mother–infant linkages were straightforward in regions with national birth registers that include identifiers for mother and infant, such as the Nordic countries, and within integrated delivery networks in the US that provide both health insurance and care. Although most mother–infant linkages used deterministic methods, probabilistic methods typically achieved greater linkage proportions while requiring more data fields. Validations were uncommon; two studies demonstrated high positive predictive value (> 95%) but lower sensitivity (20%–88%).Discussion: Successful mother–infant data linkage occurs throughout the world and is enabled by aligned health care and technology infrastructure and policy. To increase trust in evidence generated from linked data, we encourage researchers and journals to include a description of linking methods, a quantification of linkage success, and, when possible, an assessment of linkage validity in peer‐reviewed publications.
- 26 June 2025
- Published by Springer Nature in Metabolomics
- Vol. 21 (4) , 1-15
Exploratory untargeted metabolomics analysis reveals differences in metabolite profiles in pregnant people exposed vs. unexposed to E-cigarettes secondhand in the NYU children’s health and environment study
Introduction Secondhand exposure to e-cigarettes represents a potential population health risk given e-cigarette’s prevalence and their unknown health effects, particularly among vulnerable populations such as pregnant people. Objectives To explore metabolomic differences between pregnant people exposed vs. not exposed to secondhand e-cigarette aeresols, to identify possible biomarkers of exposure and metabolic pathways perturbed by e-cigarettes. Methods Exposed participants (n = 19) from the NYU Children’s Health and Environment Study were matched to unexposed participants (n = 57) at a 1:3 ratio on age, hospital of recruitment, and race/ethnicity. Early-pregnancy urine samples were analyzed via an untargeted metabolomics platform using reverse-phase liquid chromatography mass-spectrometry. Feature-exposure associations were estimated using conditional logistic regression to adjust for matching factors. A sensitivity analysis was conducted adjusting for secondhand tobacco exposure. Results Among features enriched in the exposed group were flavonoids and flavor-related compounds including homoeriodictyol and naringenin-7-O-beta-D-glucuronide, 3-acetomidocoumarin, and guaiacol pentosylglucoside; synthetic drugs such as the endocannabinoid AM1172 and the stimulant alpha-PVP; and metabolites associated with lipid metabolism, including 2,4-undecadiene-8,10-diynoic acid isobutylamide, palmitamide, glycerol trihexanoate, and tetradecyl phosphonate. Among features negatively associated with exposure were xanthines. Conclusion This study is the first untargeted metabolomics study investigating metabolomic markers of e-cigarette exposure, including secondhand exposure, in a pregnant cohort. Despite this study’s small size and exploratory nature, the results of this work suggest that flavoring components could be biomarkers for e-cigarette exposure, and that co-exposure to e-cigarettes and other drugs may be prevalent.
- 26 June 2025
- Published by Springer Nature in Metabolomics
- Vol. 21 (4) , 1-15
Exploratory untargeted metabolomics analysis reveals differences in metabolite profiles in pregnant people exposed vs. unexposed to E-cigarettes secondhand in the NYU children’s health and environment study
Introduction Secondhand exposure to e-cigarettes represents a potential population health risk given e-cigarette’s prevalence and their unknown health effects, particularly among vulnerable populations such as pregnant people. Objectives To explore metabolomic differences between pregnant people exposed vs. not exposed to secondhand e-cigarette aeresols, to identify possible biomarkers of exposure and metabolic pathways perturbed by e-cigarettes. Methods Exposed participants (n = 19) from the NYU Children’s Health and Environment Study were matched to unexposed participants (n = 57) at a 1:3 ratio on age, hospital of recruitment, and race/ethnicity. Early-pregnancy urine samples were analyzed via an untargeted metabolomics platform using reverse-phase liquid chromatography mass-spectrometry. Feature-exposure associations were estimated using conditional logistic regression to adjust for matching factors. A sensitivity analysis was conducted adjusting for secondhand tobacco exposure. Results Among features enriched in the exposed group were flavonoids and flavor-related compounds including homoeriodictyol and naringenin-7-O-beta-D-glucuronide, 3-acetomidocoumarin, and guaiacol pentosylglucoside; synthetic drugs such as the endocannabinoid AM1172 and the stimulant alpha-PVP; and metabolites associated with lipid metabolism, including 2,4-undecadiene-8,10-diynoic acid isobutylamide, palmitamide, glycerol trihexanoate, and tetradecyl phosphonate. Among features negatively associated with exposure were xanthines. Conclusion This study is the first untargeted metabolomics study investigating metabolomic markers of e-cigarette exposure, including secondhand exposure, in a pregnant cohort. Despite this study’s small size and exploratory nature, the results of this work suggest that flavoring components could be biomarkers for e-cigarette exposure, and that co-exposure to e-cigarettes and other drugs may be prevalent.
- Open Access
- 20 March 2024
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 115 (6) , 1251-1257
A Benefit–Risk Conceptual Framework for Biologic Use During Pregnancy: A Mini‐Review
Recent reports related to in utero exposure of marketed immunosuppressive biologics led to clinical recommendations to delay live vaccinations for infants due to the concern of reduced vaccine effectiveness and/or increased risk of vaccine-related disease. These delays can increase the risk of children contracting vaccine preventable diseases, yet the alternative cessation of biologics during pregnancy may result in increased autoimmune disease activity for the pregnant person, raising complex benefit–risk (B-R) considerations and trade-offs. Our goal is to develop a conceptual framework for B-R assessment based on the key benefits and risks pregnant people would consider for themselves and their children when continuing (vs. discontinuing) a biologic during pregnancy. The proposed framework defines the decision contexts, key domains and attributes for potential benefits, and risks of biologic use during pregnancy, informed by a literature review of indications for biologics and refined with key clinical stakeholders. The framework includes both the pregnant person taking the biologic and the infant potentially exposed to the biologic in utero, with potential benefit and risk domains and attributes for each participant. To advance this conceptual framework, there are considerations of potential biases and uncertainty of available data that will be imperative to address when quantifying the B-R framework. For these reasons, we recommend the formation of a consortium to ensure development of a robust, validated framework that can be adopted in the healthcare setting.
- 20 March 2024
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 115 (6) , 1251-1257
Open AccessA Benefit–Risk Conceptual Framework for Biologic Use During Pregnancy: A Mini‐Review
Recent reports related to in utero exposure of marketed immunosuppressive biologics led to clinical recommendations to delay live vaccinations for infants due to the concern of reduced vaccine effectiveness and/or increased risk of vaccine-related disease. These delays can increase the risk of children contracting vaccine preventable diseases, yet the alternative cessation of biologics during pregnancy may result in increased autoimmune disease activity for the pregnant person, raising complex benefit–risk (B-R) considerations and trade-offs. Our goal is to develop a conceptual framework for B-R assessment based on the key benefits and risks pregnant people would consider for themselves and their children when continuing (vs. discontinuing) a biologic during pregnancy. The proposed framework defines the decision contexts, key domains and attributes for potential benefits, and risks of biologic use during pregnancy, informed by a literature review of indications for biologics and refined with key clinical stakeholders. The framework includes both the pregnant person taking the biologic and the infant potentially exposed to the biologic in utero, with potential benefit and risk domains and attributes for each participant. To advance this conceptual framework, there are considerations of potential biases and uncertainty of available data that will be imperative to address when quantifying the B-R framework. For these reasons, we recommend the formation of a consortium to ensure development of a robust, validated framework that can be adopted in the healthcare setting.
- Open Access
- 10 April 2023
- Published by Elsevier in Environment International
- Vol. 174, 107922
Maternal urinary bisphenols and phthalates in relation to estimated fetal weight across mid to late pregnancy
- 10 April 2023
- Published by Elsevier in Environment International
- Vol. 174, 107922
Open AccessMaternal urinary bisphenols and phthalates in relation to estimated fetal weight across mid to late pregnancy
- Open Access
Development and evaluation of an algorithm to link mothers and infants in two US commercial healthcare claims databases for pharmacoepidemiology research
Background Administrative healthcare claims databases are used in drug safety research but are limited for investigating the impacts of prenatal exposures on neonatal and pediatric outcomes without mother-infant pair identification. Objective We developed a mother-infant linkage algorithm and evaluated it in two, large US commercially insured populations. Study Design We used two US commercial health insurance claims databases during the years 2000 to 2021. Mother-infant links were constructed where persons of female sex 12-55 years of age with a pregnancy episode ending in live birth were associated with a person who was 0 years of age at database entry, who shared a common insurance plan ID, had overlapping insurance coverage time, and whose date of birth was within ±60-days of the mother’s pregnancy episode live birth date. We compared the characteristics of linked vs non-linked mothers and infants to assess similarity. Results The algorithm linked 3,477,960 mothers to 4,160,284 infants in the two databases. Linked mothers and linked infants comprised 73.6% of all mothers and 49.1% of all-infants, respectively. 94.9% of linked infants’ dates of birth were within ±30-days of the associated mother’s pregnancy episode end dates. Linked mothers were older, had longer pregnancy episodes, and had greater post-pregnancy observation time than mothers with live births who did not meet linkage algorithm criteria. Linked infants had less observation time and greater healthcare utilization than non-linked infants. Other characteristics were similar in linked vs non-linked mothers and infants. Conclusion We developed a mother-infant linkage algorithm and applied it to two US commercial healthcare claims databases that achieved a high linkage proportion and demonstrated that linked and non-linked mother and infant cohorts were similar. Transparent, reusable algorithms applied to large databases enables large-scale research on exposures during pregnancy and pediatric outcomes with relevance to drug safety. These features suggest that prenatal exposure causal risk assessment that uses this algorithm can produce valid and generalizable evidence to inform clinical, policy, and regulatory decisions. Key points A. Why was this study conducted? -This study establishes reliable mother-infant links in two US commercial healthcare databases to facilitate research on prenatal exposures and infant health outcomes B. What are the key findings? -Linked mothers with live births comprise 73.6% of all mothers with live births and linked infants comprise 49.1% of all infants -Linked vs. non-linked mother and infant cohorts have similar demographic and clinical profiles -Substantial linked coverage and linked vs non-linked characteristic similarity suggests that prenatal exposure causal risk assessment using the linked cohorts will produce valid and generalizable evidence C. What does this study add to what is already known? -This study created large mother-infant linked cohorts to enable research on rare exposures and outcomes available in healthcare claims databases -Linked mother and infant coverage is similar to that reported in previous linkage studies -Descriptive comparisons between linked vs. non-linked mother and infant cohorts increases confidence that results from research on linked cohorts also apply to mother and infant populations that do not meet linkage algorithm criteria -This mother-infant linkage algorithm is publicly available and easily implemented in databases converted to a common data model
Open AccessDevelopment and evaluation of an algorithm to link mothers and infants in two US commercial healthcare claims databases for pharmacoepidemiology research
Background Administrative healthcare claims databases are used in drug safety research but are limited for investigating the impacts of prenatal exposures on neonatal and pediatric outcomes without mother-infant pair identification. Objective We developed a mother-infant linkage algorithm and evaluated it in two, large US commercially insured populations. Study Design We used two US commercial health insurance claims databases during the years 2000 to 2021. Mother-infant links were constructed where persons of female sex 12-55 years of age with a pregnancy episode ending in live birth were associated with a person who was 0 years of age at database entry, who shared a common insurance plan ID, had overlapping insurance coverage time, and whose date of birth was within ±60-days of the mother’s pregnancy episode live birth date. We compared the characteristics of linked vs non-linked mothers and infants to assess similarity. Results The algorithm linked 3,477,960 mothers to 4,160,284 infants in the two databases. Linked mothers and linked infants comprised 73.6% of all mothers and 49.1% of all-infants, respectively. 94.9% of linked infants’ dates of birth were within ±30-days of the associated mother’s pregnancy episode end dates. Linked mothers were older, had longer pregnancy episodes, and had greater post-pregnancy observation time than mothers with live births who did not meet linkage algorithm criteria. Linked infants had less observation time and greater healthcare utilization than non-linked infants. Other characteristics were similar in linked vs non-linked mothers and infants. Conclusion We developed a mother-infant linkage algorithm and applied it to two US commercial healthcare claims databases that achieved a high linkage proportion and demonstrated that linked and non-linked mother and infant cohorts were similar. Transparent, reusable algorithms applied to large databases enables large-scale research on exposures during pregnancy and pediatric outcomes with relevance to drug safety. These features suggest that prenatal exposure causal risk assessment that uses this algorithm can produce valid and generalizable evidence to inform clinical, policy, and regulatory decisions. Key points A. Why was this study conducted? -This study establishes reliable mother-infant links in two US commercial healthcare databases to facilitate research on prenatal exposures and infant health outcomes B. What are the key findings? -Linked mothers with live births comprise 73.6% of all mothers with live births and linked infants comprise 49.1% of all infants -Linked vs. non-linked mother and infant cohorts have similar demographic and clinical profiles -Substantial linked coverage and linked vs non-linked characteristic similarity suggests that prenatal exposure causal risk assessment using the linked cohorts will produce valid and generalizable evidence C. What does this study add to what is already known? -This study created large mother-infant linked cohorts to enable research on rare exposures and outcomes available in healthcare claims databases -Linked mother and infant coverage is similar to that reported in previous linkage studies -Descriptive comparisons between linked vs. non-linked mother and infant cohorts increases confidence that results from research on linked cohorts also apply to mother and infant populations that do not meet linkage algorithm criteria -This mother-infant linkage algorithm is publicly available and easily implemented in databases converted to a common data model
- 14 October 2022
- Published by Wiley in Journal of Traumatic Stress
- Vol. 36 (1) , 44-58
Posttraumatic stress disorder and functional impairment among World Trade Center Health Registry enrollees 14–15 years after the September 11, 2001, terrorist attacks
The September 11, 2001, terrorist attacks on the World Trade Center (WTC) in New York City (9/11) had health‐related consequences, including posttraumatic stress disorder (PTSD). PTSD is associated with functional impairment, which varies by symptom severity and other factors. This study aimed to identify predictors of functional impairment in individuals with low versus high PTSD symptom severity levels. WTC Health Registry enrollees exposed to 9/11 were surveyed four times between 2003 and 2015; cumulated data for individuals who endorsed at least one symptom on the PTSD Checklist–Civilian Version (PCL‐C) at Wave 4 (2015–2016) were included (N = 30,287) and examined cross‐sectionally. Individuals were classified based on PCL‐C scores as having low/no (2–29) or high levels of PTSD symptom severity (≥ 44). Functional impairment was defined as subsequent difficulties in daily living. Among low/no PTSD severity participants, adjusted odds ratios (aORs) for the associations between functional impairment and poor self‐rated health (vs. good), low social support (vs. high), and no physical activity (vs. active) were 1.23–1.92. In the same group, low versus high household income was associated with more functional impairment, aOR = 1.34, 95% CI [1.13, 1.59]. Among participants with high‐level PTSD symptoms, women, aOR = 1.70, 95% CI [1.31, 2.20], and Hispanic enrollees, aOR = 1.76, 95% CI [1.31, 2.36], were more likely to report an absence of impairment. Self‐rated health, social support, and physical activity emerged as important predictors of PTSD‐related functional impairment across PTSD symptom severity levels, supporting clinical interventions targeting these factors.
- 14 October 2022
- Published by Wiley in Journal of Traumatic Stress
- Vol. 36 (1) , 44-58
Posttraumatic stress disorder and functional impairment among World Trade Center Health Registry enrollees 14–15 years after the September 11, 2001, terrorist attacks
The September 11, 2001, terrorist attacks on the World Trade Center (WTC) in New York City (9/11) had health‐related consequences, including posttraumatic stress disorder (PTSD). PTSD is associated with functional impairment, which varies by symptom severity and other factors. This study aimed to identify predictors of functional impairment in individuals with low versus high PTSD symptom severity levels. WTC Health Registry enrollees exposed to 9/11 were surveyed four times between 2003 and 2015; cumulated data for individuals who endorsed at least one symptom on the PTSD Checklist–Civilian Version (PCL‐C) at Wave 4 (2015–2016) were included (N = 30,287) and examined cross‐sectionally. Individuals were classified based on PCL‐C scores as having low/no (2–29) or high levels of PTSD symptom severity (≥ 44). Functional impairment was defined as subsequent difficulties in daily living. Among low/no PTSD severity participants, adjusted odds ratios (aORs) for the associations between functional impairment and poor self‐rated health (vs. good), low social support (vs. high), and no physical activity (vs. active) were 1.23–1.92. In the same group, low versus high household income was associated with more functional impairment, aOR = 1.34, 95% CI [1.13, 1.59]. Among participants with high‐level PTSD symptoms, women, aOR = 1.70, 95% CI [1.31, 2.20], and Hispanic enrollees, aOR = 1.76, 95% CI [1.31, 2.36], were more likely to report an absence of impairment. Self‐rated health, social support, and physical activity emerged as important predictors of PTSD‐related functional impairment across PTSD symptom severity levels, supporting clinical interventions targeting these factors.
- 30 June 2022
- Published by Wolters Kluwer Health in Kidney360
- Vol. 3 (6) , 1011-1020
Urinary Polycyclic Aromatic Hydrocarbons in a Longitudinal Cohort of Children with CKD: A Case of Reverse Causation?
Key Points: Serially measured polycyclic aromatic hydrocarbon (PAH) metabolites were associated with increased eGFR and lower proteinuria. PAHs were associated with higher tubular injury and oxidant stress biomarkers. Reduced renal function may affect excretion of urinary PAHs. Background: Air pollution, which results in the formation of polycyclic aromatic hydrocarbons (PAHs), has been identified as a cause of renal function decline and a contributor to CKD. However, the results of cross-sectional studies investigating personal, integrated biomarkers of PAHs have been mixed. Longitudinal studies may be better suited to evaluate environmental drivers of kidney decline. The purpose of this study was to examine associations of serially measured urinary PAH metabolites with clinical and subclinical measures of kidney function over time among children with CKD. Methods: This study was conducted among 618 participants in the Chronic Kidney Disease in Children study, a cohort study of pediatric patients with CKD from the United States and Canada, between 2005 and 2015. In serially collected urine samples over time, nine PAH metabolites were measured. Clinical outcomes measured annually included eGFR, proteinuria, and BP. Subclinical biomarkers of tubular injury (kidney injury molecule-1 [KIM-1] and neutrophil gelatinase-associated lipocalin [NGAL]) and oxidant stress (8-hydroxy-2′-deoxyguanosine [8-OHdG] and F2-isoprostane) were assayed in urine samples. Results: Children were followed over an average (SD) of 3.0 (1.6) years and 2469 study visits (mean±SD, 4.0±1.6). Hydroxynaphthalene (NAP) or hydroxyphenanthrene (PHEN) metabolites were detected in >99% of samples and NAP concentrations were greater than PHEN concentrations. PHEN metabolites, driven by 3-PHEN, were associated with increased eGFR and reduced proteinuria, diastolic BP z-score, and NGAL concentrations over time. However, PAH metabolites were consistently associated with increased KIM-1 and 8-OHdG concentrations. Conclusions: Among children with CKD, these findings provoke the potential explanation of reverse causation, where renal function affects measured biomarker concentrations, even in the setting of a longitudinal study. Additional work is needed to determine if elevated KIM-1 and 8-OHdG excretion reflects site-specific injury to the proximal tubule mediated by low-grade oxidant stress.
- 30 June 2022
- Published by Wolters Kluwer Health in Kidney360
- Vol. 3 (6) , 1011-1020
Urinary Polycyclic Aromatic Hydrocarbons in a Longitudinal Cohort of Children with CKD: A Case of Reverse Causation?
Key Points: Serially measured polycyclic aromatic hydrocarbon (PAH) metabolites were associated with increased eGFR and lower proteinuria. PAHs were associated with higher tubular injury and oxidant stress biomarkers. Reduced renal function may affect excretion of urinary PAHs. Background: Air pollution, which results in the formation of polycyclic aromatic hydrocarbons (PAHs), has been identified as a cause of renal function decline and a contributor to CKD. However, the results of cross-sectional studies investigating personal, integrated biomarkers of PAHs have been mixed. Longitudinal studies may be better suited to evaluate environmental drivers of kidney decline. The purpose of this study was to examine associations of serially measured urinary PAH metabolites with clinical and subclinical measures of kidney function over time among children with CKD. Methods: This study was conducted among 618 participants in the Chronic Kidney Disease in Children study, a cohort study of pediatric patients with CKD from the United States and Canada, between 2005 and 2015. In serially collected urine samples over time, nine PAH metabolites were measured. Clinical outcomes measured annually included eGFR, proteinuria, and BP. Subclinical biomarkers of tubular injury (kidney injury molecule-1 [KIM-1] and neutrophil gelatinase-associated lipocalin [NGAL]) and oxidant stress (8-hydroxy-2′-deoxyguanosine [8-OHdG] and F2-isoprostane) were assayed in urine samples. Results: Children were followed over an average (SD) of 3.0 (1.6) years and 2469 study visits (mean±SD, 4.0±1.6). Hydroxynaphthalene (NAP) or hydroxyphenanthrene (PHEN) metabolites were detected in >99% of samples and NAP concentrations were greater than PHEN concentrations. PHEN metabolites, driven by 3-PHEN, were associated with increased eGFR and reduced proteinuria, diastolic BP z-score, and NGAL concentrations over time. However, PAH metabolites were consistently associated with increased KIM-1 and 8-OHdG concentrations. Conclusions: Among children with CKD, these findings provoke the potential explanation of reverse causation, where renal function affects measured biomarker concentrations, even in the setting of a longitudinal study. Additional work is needed to determine if elevated KIM-1 and 8-OHdG excretion reflects site-specific injury to the proximal tubule mediated by low-grade oxidant stress.